Anticoagulation Market Key Manufacturers
Pulmonary embolism (PE) has emerged as a critical driver in the Anticoagulation Market. PE is a life-threatening condition that requires immediate anticoagulation therapy. The increasing incidence of PE due to sedentary lifestyles,
aging populations, and postoperative complications has significantly boosted demand for anticoagulants. Early diagnosis through advanced imaging techniques allows timely intervention, reducing morbidity and mortality. Pharmaceutical companies are focusing on targeted therapies for PE management, improving patient safety and treatment efficacy. As awareness and diagnostic capabilities improve globally, the PE segment is expected to continue contributing strongly to market growth.